ArticleFrontiers in oncology2026
Small intestine choriocarcinoma with brain, lung and liver metastases in a male patient: a case report.
Article in Frontiers in oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Extragonadal non-gestational choriocarcinama, especially in the gastrointestinal tract, is exceptionally rare. It often presents with metastatic disease and nonspecific symptoms, leading to diagnostic delays. Case report: Herein, we reported a 61-year-old male patient diagnosed with small intestine choriocarcinoma with metastases of brain, lung, liver and lymph nodes. This patient presented initially with black stools, heart palpitations and chest tightness. After diagnosis, the patient received chemotherapy with etoposide and cisplatin. The patient demonstrated a robust clinical and biochemical response to chemotherapy, with a significant reduction in β-HCG levels and increase of hemoglobin. Follow-up imaging demonstrated a decreased size of pulmonary and liver metastases. Conclusions: Because of the complex nature of extragonadal non-gestational choriocarcinama, diagnosis is often delayed. The present case highlight the necessity for high clinical suspicion, and early initiation of treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.